Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (390857198)
Terveyden Tutkimuksen Toimikunta (334802, 315459, 307866)
H2020 Marie Skłodowska-Curie Actions (740264)
Academy of Finland (330178)
Received: 25 February 2020
Accepted: 6 September 2020
First Online: 11 September 2020
Ethics approval and consent to participate
: Animals were raised and handled at the DZNE, Munich, and at the Laboratory Animal Center of the University of Eastern Finland, Kuopio. All animal experiments were carried out in accordance with the guidelines of the European Community Council Directives 86/609/EEC and approved by the Bavarian government and the Animal Experiment Board of Finland (ESAVI 21203–2019, EKS-004-2019).
: Not applicable.
: C.H. collaborates with Denali Therapeutics, is the chief scientific advisor of ISAR Biosciences, participated on one advisory board meeting of Biogen, and received a speaker honorarium from Novartis and Roche. M.H. is a member of global diagnostics AD-board, Roche.